drugset / Trial / NCT01016834
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
Timeline
- Start
- 2009-11-30
- Primary completion
- 2010-04-30
- Completion
- 2010-04-30
Outcome
Met primary endpoint
paper PPMQ-R Overall Satisfaction (primary endpoint) increased significantly from baseline to the end of treatment PMID 21812775 ↗
Publications
- Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence. Curr Med Res Opin. 2011 Nov;27(11):2185-91. doi: 10.1185/03007995.2011.619177. Epub 2011 Sep 26.
- Cady RK, Aurora SK, Brandes JL, Rothrock JF, Myers JA, Fox AW, Farr SJ. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans. Headache. 2011 Sep;51(8):1202-11. doi: 10.1111/j.1526-4610.2011.01972.x. Epub 2011 Aug 3.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sumatriptan | Unknown | 6 mg | Subcutaneous |